Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydrogen-Rich Celsior Solution in Aging Liver/Kidney Transplantation
NCT02613195Phase 3Unknown
- Sponsor
- Renji Hospital
- Start
- Jan 2016
- Primary completion
- Feb 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Hydrogen-Rich Celsior in ischemia-reperfusion injury (IRI), sponsored by Renji Hospital. Status: unknown.
02
Drugs
Hydrogen-Rich Celsior
03
Conditions
ischemia-reperfusion injury (IRI)
Beyond the preview
Go deeper on NCT02613195.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02613195.